Mesoblast (NASDAQ: MESO) reported Q2 EPS of ($0.06), versus ($0.09) reported last year. Revenue for the quarter came in at $4 million, versus $4.4 million reported last year.

For earnings history and earnings-related data on Mesoblast (MESO) click here.